| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a703695f605ded296e3ff7b8bb45ea88 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 |
| filingDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eae6f9dad01ab188ea8d9001ce490d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4bb851ca2029e61ab315a2ff75ded5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeacb585161b7b9fa8a9759934d6614a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01ac01792ce7e42ed114898610120a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83e4c6da09e33c6831f5119ceec5c307 |
| publicationDate |
2020-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202007401-A |
| titleOfInvention |
Lactic acid bacteria composition for inhibiting gastritis caused by Helicobacter pylori and its use |
| abstract |
The present invention provides a pharmaceutical composition and food product for inhibiting gastritis caused by gastric Helicobacter pylori, which comprises lactic acid bacteria selected from Lactobacillus rhamnosus GM-020 (also known as GMNL-74), Deposit numbers are BCRC910236 and CCTCC M203098; Lactobacillus acidophilus GMNL-185, deposit numbers BCRC910774 and CCTCC M2017764 and Lactobacillus plantarum GMNL-662, deposit numbers BCRC910738 and CCTCC M2016571 and any two Groups combined above. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112746034-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112746034-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I792249-B |
| priorityDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |